Sera Prognostics Stock Total Asset
| SERA Stock | USD 7.20 0.20 2.70% |
Sera Prognostics fundamentals help investors to digest information that contributes to Sera Prognostics' financial success or failures. It also enables traders to predict the movement of Sera Stock. The fundamental analysis module provides a way to measure Sera Prognostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sera Prognostics stock.
Sera |
Sera Prognostics Company Total Asset Analysis
Sera Prognostics' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Sera Prognostics Total Asset | 95.44 M |
Most of Sera Prognostics' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sera Prognostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Sera Total Asset Historical Pattern
Today, most investors in Sera Prognostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sera Prognostics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Sera Prognostics total asset as a starting point in their analysis.
Sera Prognostics Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, Sera Prognostics has a Total Asset of 95.44 M. This is 98.73% lower than that of the Biotechnology sector and 96.93% lower than that of the Health Care industry. The total asset for all United States stocks is 99.68% higher than that of the company.
Sera Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sera Prognostics' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sera Prognostics could also be used in its relative valuation, which is a method of valuing Sera Prognostics by comparing valuation metrics of similar companies.Sera Prognostics is currently under evaluation in total asset category among its peers.
Sera Prognostics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sera Prognostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sera Prognostics' managers, analysts, and investors.Environmental | Governance | Social |
Sera Prognostics Institutional Holders
Institutional Holdings refers to the ownership stake in Sera Prognostics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sera Prognostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sera Prognostics' value.| Shares | Citadel Advisors Llc | 2024-06-30 | 109.2 K | Ensign Peak Advisors Inc | 2024-06-30 | 102.2 K | Bridgeway Capital Management, Llc | 2024-06-30 | 86.1 K | Perigon Wealth Management, Llc | 2024-06-30 | 85.2 K | Resolute Capital Asset Partners Llc | 2024-06-30 | 80 K | Charles Schwab Investment Management Inc | 2024-06-30 | 77.1 K | Millennium Management Llc | 2024-06-30 | 64.9 K | Requisite Capital Management, Llc | 2024-06-30 | 55.6 K | Ballentine Finn & Company Inc | 2024-06-30 | 49.7 K | Baker Bros Advisors Lp | 2024-06-30 | 5.4 M | Ra Capital Management, Llc | 2024-06-30 | 3 M |
Sera Fundamentals
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.24 | ||||
| Operating Margin | (385.54) % | ||||
| Current Valuation | 196.68 M | ||||
| Shares Outstanding | 32.4 M | ||||
| Shares Owned By Insiders | 12.74 % | ||||
| Shares Owned By Institutions | 71.48 % | ||||
| Number Of Shares Shorted | 811.38 K | ||||
| Price To Book | 4.12 X | ||||
| Price To Sales | 2,245 X | ||||
| Revenue | 306 K | ||||
| Gross Profit | 75 K | ||||
| EBITDA | (38.62 M) | ||||
| Net Income | (36.24 M) | ||||
| Cash And Equivalents | 106.91 M | ||||
| Cash Per Share | 3.45 X | ||||
| Total Debt | 1.86 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.80 X | ||||
| Book Value Per Share | 1.79 X | ||||
| Cash Flow From Operations | (27.19 M) | ||||
| Short Ratio | 8.30 X | ||||
| Earnings Per Share | (0.98) X | ||||
| Target Price | 2.75 | ||||
| Number Of Employees | 55 | ||||
| Beta | 1.03 | ||||
| Market Capitalization | 240.25 M | ||||
| Total Asset | 95.44 M | ||||
| Retained Earnings | (246.9 M) | ||||
| Working Capital | 36.9 M | ||||
| Net Asset | 95.44 M |
About Sera Prognostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sera Prognostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sera Prognostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sera Prognostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Sera Stock
When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:Check out Sera Prognostics Piotroski F Score and Sera Prognostics Altman Z Score analysis. For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.98) | Revenue Per Share 0.003 | Quarterly Revenue Growth (0.81) | Return On Assets (0.24) | Return On Equity (0.45) |
The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.